Skip to main content
. 2018 May 30;2018:9596054. doi: 10.1155/2018/9596054

Figure 1.

Figure 1

Plasma concentrations of plasminogen activator inhibitor-1 (PAI-1) in nondiabetic obese and lean participants (obese: 6.58 [5–8.58] and control: 2.93 [1.8–5.23] ng/ml; p < 0.001).